To ensure the accuracy and sensitivity of the biochemical assessments, all ELISA kits were sourced from reputable manufacturers (Bio-Rad Laboratories, USA
While trials used 6 mg, 12 mg, and 36 mg doses, Lilly conducted pharmacokinetic studies to establish equivalent doses of 9 mg, 14.5 mg, and 17.2 mg for manufacturing
This new micro coring technology reduces the skin's surface area by 3-8% per treatment
Our passion for people extends into the communities we serve
A new study from the UK Medical C*nnabis Registry brings hopeful insights: Patients reported measurable reductions in pain over 6 months Improvements in sleep, anxiety, and overall quality of life Findings highlight c*nnabis-based medicines as a promising option for CRPS management Read the full study here #GreenleafMedClinic #ChronicPainRelief #MedicalResearch #NeuropathicPain #CRPS To view or add a comment, sign in GLP-1s for everything? Once just for diabetes and weight loss, GLP-1 receptor agonists are now being studied for obstructive sleep apnea, substance use disorder, Alzheimers, and more
[DOI] [PubMed] [Google Scholar] 64.Nakamura Y, Shimetani A, Fujii H, Amano O, Sakagami H, Takahashi K
